2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma
Crossref DOI link: https://doi.org/10.1007/s13277-015-3816-1
Published Online: 2015-07-29
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lin, Han
Jiang, Xian
Zhu, Huaqiang
Jiang, Wenjing
Dong, Xuesong
Qiao, Haiquan
Sun, Xueying
Jiang, Hongchi
Text and Data Mining valid from 2015-07-29